Version 5.4
Bos taurus Gene: BCKDHA
Summary
InnateDB Gene IDBG-638445.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BCKDHA
Gene Name 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial precursor
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000016037
Encoded Proteins
IDBP-690523
2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial precursor
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000255730:
Gene Information
Type Protein coding
Genomic Location Chromosome 18:50819358-50838361
Strand Forward strand
Band
Transcripts
ENSBTAT00000021342 ENSBTAP00000021342
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0016624 oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor
Biological Process
GO:0008152 metabolic process
GO:0055114 oxidation-reduction process
Cellular Component
GO:0005739 mitochondrion
Orthologs
Species
Mus musculus
Homo sapiens
Gene ID
Gene Order
ENSMUSG00000060376
View Gene Order
ENSG00000255730
View Gene Order
Pathway Predictions based on Human Orthology Data
NETPATH
REACTOME
KEGG
mmu00280
Valine, leucine and isoleucine degradation pathway
INOH
PID NCI
Cross-References
SwissProt
TrEMBL F1N5F2
UniProt Splice Variant
Entrez Gene 282149
UniGene Bt.5287
RefSeq NM_174506
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02047109 DAAA02047110
GenPept
RNA Seq Atlas 282149

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca